FMR LLC 13D and 13G filings for Cerevel Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-10 10:03 am Sale |
2024-05-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
FMR LLC | 522,877 0.287% |
-9,168,974 (-94.60%) |
Filing |
| 2024-01-10 08:53 am Sale |
2024-01-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
FMR LLC | 9,691,851 5.365% |
-13,761,937 (-58.68%) |
Filing |
| 2023-02-09 09:59 am Purchase |
2023-02-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
FMR LLC | 23,453,788 14.999% |
3,943,975 (+20.22%) |
Filing |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
FMR LLC | 19,509,813 13.250% |
2,935,922 (+17.71%) |
Filing |
| 2021-08-10 10:33 am Purchase |
2021-08-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
FMR LLC | 16,573,891 11.727% |
16,573,891 (New Position) |
Filing |